01:29 AM EDT, 10/15/2026 (MT Newswires) -- DocMorris (DOCM.SW) logged a year-over-year growth in revenue for the third quarter, a Thursday filing showed. For the three months ended Sept. 30, revenue was 327.4 million francs versus 268.1 million francs previously, the Switzerland-listed online pharmacy company said. For 2026, the company lifted its external revenue growth outlook to between 12.5% and 15% from 9% to 13% previously. It also affirmed its medium-term targets.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.